ARTICLE | Company News
AmorChem, McGill University deal
January 6, 2014 8:00 AM UTC
On Dec. 17, 2013, life science VC fund AmorChem invested an undisclosed amount to discover inflammatory drugs targeting an undisclosed deubiquitinating (DUB) enzyme discovered at the university. AmorC...